Overview

The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery

Status:
Recruiting
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether administration of a non-centrally acting muscle relaxants will improve the Overall Benefit of Analgesia Score (OBAS), and Richmond Agitation Sedation Scale (RASS) scores in patients undergoing lumbar fusion.
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Dantrolene